Knockdown of HOTAIRM1 or HOXA1 could re-sensitize TAMR cells to tamoxifen treatment, suggesting that the HOTAIRM1/HOXA1 axis contributes to tamoxifen resistance in breast cancer. The gene discussed is HOXA1; the disease is breast cancer.